Evidence map›Paper›PMID 34981214›Full record

ArticleOral and maxillofacial surgery2022

Massive macroglossia, a rare side effect of COVID-19: clinical, histologic, and genomic findings in COVID-19-positive versus COVID-19-negative patients.

Victoria A Mañón, David Chubb, Laura S Farach, Rachid Karam, Mary C Farach-Carson, Nadarajah Vigneswaran, Karan Saluja, Simon Young, Mark Wong, James C Melville

Open access · bronzeAbstract read
In one paragraph

Article in Oral and maxillofacial surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Victoria A MañónBernard and Gloria Pepper Katz Department of Oral & Maxillofacial Surgery, The University of Texas at Houston, TX, 77054, Houston, USA. Victoria.A.Manon@uth.tmc.edu.
David ChubbBernard and Gloria Pepper Katz Department of Oral & Maxillofacial Surgery, The University of Texas at Houston, TX, 77054, Houston, USA.
Laura S FarachDepartment of Pediatrics, McGovern Medical School, The University of Texas Health Science Center, Houston, USA.
Rachid KaramDepartment of Research and Development, Ambry Genetics, Aliso Viejo, CA, 92656, USA.
Mary C Farach-CarsonDepartment of Diagnostic and Biomedical Sciences, The University of Texas at Houston, Houston, USA.
Nadarajah VigneswaranDepartment of Diagnostic and Biomedical Sciences, The University of Texas at Houston, Houston, USA.
Karan SalujaDepartment of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, USA.
Simon YoungBernard and Gloria Pepper Katz Department of Oral & Maxillofacial Surgery, The University of Texas at Houston, TX, 77054, Houston, USA.
Mark WongBernard and Gloria Pepper Katz Department of Oral & Maxillofacial Surgery, The University of Texas at Houston, TX, 77054, Houston, USA.
James C MelvilleHead and Neck Oncologic and Microvascular Reconstructive Surgery, Bernard and Gloria Pepper Katz Department of Oral & Maxillofacial Surgery Department of Oral & Maxillofacial Surgery, The University of Texas at Houston, Houston, USA.
The University of Texas Health Science Center at Houston · USAmbry Genetics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe primary purpose of this study is to identify if there is an underlying genetic predisposition for COVID-related macroglossia and if this susceptibility is higher among individuals of African heritage. Secondary objectives include determining if genetic testing of COVID-infected patients who are intubated and prone could identify patients with higher susceptibility to the development of macroglossia.

methodsA retrospective chart review was completed for each patient, and prospectively, genetic and histopathologic analyses were completed. Whole-exome sequencing was completed on two patients; immunohistochemistry was completed on the COVID-positive tissue samples.

resultsHistopathology of the COVID-positive patient revealed significant peri-lymphocytic infiltrate, which was absent in the COVID-negative patient. Immunohistochemistry confirmed the presence of immune cells. Results from the whole-exome sequencing were inconclusive.

conclusionThe findings of this study are consistent with others that have observed a lymphocytic infiltrate in the organs of patients infected with SARS-CoV-2. On histology, IHC highlighted a CD45 + predominance, indicating that a robust immune response is present in the tissues. The pathobiology of this phenomenon and its role in the development and/or persistence of massive macroglossia requires further study.

Indexed as

COVID-19MacroglossiaGenomicsHumansRetrospective StudiesSARS-CoV-2COVID-19HistopathologyImmunohistochemistryOral pathologyOral surgery

Identifiers

PMID34981214
PMCPMC8722658
OpenAlexW4205229212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.